Literature DB >> 18345295

Nodal sampling in pancreaticoduodenectomy: does it change our management?

Roozbeh Rassadi1, Paul R Tarnasky, Jeffrey D Linder, A Joe Saad, D Rohan Jeyarajah.   

Abstract

BACKGROUND: Lymph node involvement in periampullary malignancy is the single most important factor in predicting survival in pancreaticoduodenectomy (PD). The role of nodal sampling in PD has not been well evaluated. This study evaluates the utility of nodal sampling of nodal stations 8 and 12, which are easily dissected early in PD, in overall final nodal status. PATIENTS AND METHODS: Fifty patients underwent PD at a single institution by a one surgeon over a 15 month period. Nodal stations 8 and 12 were sent separately for pathologic evaluation. Twenty-eight patients had a final diagnosis of periampullary malignancy. Demographic and pathologic data were collected retrospectively from patient charts. Positive and negative predictive values of nodes 8 and 12 were evaluated.
RESULTS: Eighteen of 28 patients with a diagnosis of periampullary malignancy had pathologically negative nodes 8 and 12, and a final nodal status (all peripancreatic lymph nodes) negative for nodal involvement. Nine of 28 patients had a negative nodal sampling result, but a positive final nodal status for metastatic tumor. The remaining four patients had both positive nodal sampling and final nodal status for metastatic tumor. The negative predictive value of negative nodes 8 and 12 was 0.625.
CONCLUSION: The negative predictive of a negative node 8 and 12 of 0.625 suggests that the decision to proceed with or abort PD should not be based on intraoperative evaluation of these nodes. Performance of PD should be undertaken if technically feasible, and not based on intraoperative nodal assessment.

Entities:  

Keywords:  Pancreaticoduodenectomy; Whipple; lymph nodes

Year:  2007        PMID: 18345295      PMCID: PMC2215361          DOI: 10.1080/13651820701713733

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  29 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

4.  Application of sentinel node biopsy to gastric cancer surgery.

Authors:  M Hiratsuka; I Miyashiro; O Ishikawa; H Furukawa; K Motomura; H Ohigashi; M Kameyama; Y Sasaki; T Kabuto; S Ishiguro; S Imaoka; H Koyama
Journal:  Surgery       Date:  2001-03       Impact factor: 3.982

5.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

6.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Jordan M Winter; Kurtis A Campbell; Ralph H Hruban; David Chang; Charles J Yeo
Journal:  Surgery       Date:  2006-08-28       Impact factor: 3.982

7.  Impact of regional lymph node evaluation in staging patients with periampullary tumors.

Authors:  Shishir K Maithel; Korosh Khalili; Elijah Dixon; Maha Guindi; Mark P Callery; Mark S Cattral; Bryce R Taylor; Steven Gallinger; Paul D Greig; David R Grant; Charles M Vollmer
Journal:  Ann Surg Oncol       Date:  2007-01       Impact factor: 5.344

Review 8.  Extended resection for pancreatic adenocarcinoma.

Authors:  Srinevas K Reddy; Douglas S Tyler; Theodore N Pappas; Bryan M Clary
Journal:  Oncologist       Date:  2007-06

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Daniel Laheru; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

10.  Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Authors:  Thomas Zacharias; Daniel Jaeck; Elie Oussoultzoglou; Agnes Neuville; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.